UPSTREAM BIO, INC. Earnings Per Share (Basic)
UPSTREAM BIO, INC. (UPB) reported Earnings Per Share (Basic) of -$0.73 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- UPSTREAM BIO, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.73.
- UPSTREAM BIO, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.75.
- UPSTREAM BIO, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.78.
- UPSTREAM BIO, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.63.
- UPSTREAM BIO, INC. earnings per share, basic for fiscal 2025 was -$2.66.
- UPSTREAM BIO, INC. earnings per share, basic for fiscal 2024 was -$5.58.
- UPSTREAM BIO, INC. earnings per share, basic for fiscal 2023 was -$12.95.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.73 10-Q · filed 2026-08-11 | -$1.47 10-Q · filed 2026-08-11 | ||
| 2026-03-31 | -$0.75 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | -$0.78 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$1.41 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$2.15 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$2.66 10-K · filed 2026-03-26 |
| 2025-09-30 | -$0.63 10-Q · filed 2025-11-05 | -$1.37 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.88 10-Q · filed 2025-11-05 | -$2.37 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-06-30 | -$0.74 10-Q · filed 2026-08-11 | -$1.25 10-Q · filed 2026-08-11 | -$1.74 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$2.82 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-03-31 | -$0.51 10-Q · filed 2026-05-13 | -$0.99 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$2.05 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$3.40 derived: net income ÷ weighted average shares · filed 2026-05-13 |
| 2024-12-31 | -$0.48 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$1.76 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$3.62 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$5.58 10-K · filed 2026-03-26 |
| 2024-09-30 | -$6.96 10-Q · filed 2025-11-05 | -$13.46 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$18.15 10-Q · filed 2025-11-05 | -$23.18 derived: net income ÷ weighted average shares · filed 2025-11-05 |
| 2024-06-30 | -$6.50 10-Q · filed 2025-08-06 | -$11.18 10-Q · filed 2025-08-06 | -$16.21 derived: net income ÷ weighted average shares · filed 2025-08-06 | -$18.36 derived: net income ÷ weighted average shares · filed 2025-08-06 |
| 2024-03-31 | -$4.68 10-Q · filed 2025-05-06 | -$9.70 derived: net income ÷ weighted average shares · filed 2025-05-06 | -$11.83 derived: net income ÷ weighted average shares · filed 2025-05-06 | |
| 2023-12-31 | -$5.03 derived: net income ÷ weighted average shares · filed 2025-03-12 | -$7.15 derived: net income ÷ weighted average shares · filed 2025-03-12 | -$12.95 10-K · filed 2025-03-12 | |
| 2023-09-30 | -$2.11 10-Q · filed 2024-11-07 | -$7.90 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |